News & Updates

Show Multimedia Only
Modified-dose nirmatrelvir-ritonavir well tolerated, effective in advanced CKD patients

Modified-dose nirmatrelvir-ritonavir well tolerated, effective in advanced CKD patients

15 Aug 2023 byChristina Lau

Modified-dose regimens of nirmatrelvir-ritonavir are well tolerated and effective in COVID-19 patients with advanced chronic kidney disease (CKD), including those on dialysis, a study by the Chinese University of Hong Kong (CUHK) has shown.

15 Aug 2023